Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Corsinel Suportx Easy Panel belt large white
23300263118
|
Corsinel Suportx Easy Panel belt large white | Belts | Stoma Appliances | 3 |
|
Corsinel Suportx Easy Panel belt XX large white
23300263120
|
Corsinel Suportx Easy Panel belt XX large white | Belts | Stoma Appliances | 3 |
|
Corsinel Suportx StomaSafe Plus ostomy belt large/extra large black
23300263095
|
Corsinel Suportx StomaSafe Plus ostomy belt large/extra large black | Belts | Stoma Appliances | 3 |
|
CovaWound Hydrocolloid dressing 15cm x 15cm square
20030400321
|
CovaWound Hydrocolloid dressing 15cm x 15cm square | Wound Management & Other Dressings | Dressings | 3 |
|
CovaWound Non-Adherent Foam Border dressing 10cm x 10cm square
20030600576
|
CovaWound Non-Adherent Foam Border dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | 3 |
|
CovaWound Non-Adherent Foam dressing 20cm x 20cm square
20030600583
|
CovaWound Non-Adherent Foam dressing 20cm x 20cm square | Wound Management & Other Dressings | Dressings | 3 |
|
CovaWound Silicone Foam Border dressing 15cm x 20cm
20030900441
|
CovaWound Silicone Foam Border dressing 15cm x 20cm | Wound Management & Other Dressings | Dressings | 3 |
|
Covonia Catarrh Relief Formula oral solution
030902000BEDDA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | 3 |
|
Cubicole D3 10,000unit capsules
0906040G0CKAGDV
|
Cubicole D3 | Colecalciferol | Nutrition and Blood | 3 |
|
Cubicole D3 2,200unit capsules
0906040G0CKADDW
|
Cubicole D3 | Colecalciferol | Nutrition and Blood | 3 |
|
Cutimed Epiona dressing 5cm x 5cm square
20033000056
|
Cutimed Epiona dressing 5cm x 5cm square | Wound Management & Other Dressings | Dressings | 3 |
|
Cutimed Siltec L dressing 15cm x 15cm
20030900107
|
Cutimed Siltec L dressing 15cm x 15cm | Wound Management & Other Dressings | Dressings | 3 |
|
Cutimed Siltec L dressing 5cm x 6cm
20030900105
|
Cutimed Siltec L dressing 5cm x 6cm | Wound Management & Other Dressings | Dressings | 3 |
|
Cutimed Siltec Sorbact B dressing 22.5cm x 22.5cm
20031600115
|
Cutimed Siltec Sorbact B dressing 22.5cm x 22.5cm | Wound Management & Other Dressings | Dressings | 3 |
|
Cutimed Sorbact Hydroactive dressing 19cm x 19cm
20031600085
|
Cutimed Sorbact Hydroactive dressing 19cm x 19cm | Wound Management & Other Dressings | Dressings | 3 |
|
Cynril 1.6mg lozenges with integral oromucosal applicator
0407020A0BWAFAP
|
Cynril | Fentanyl | Central Nervous System | 3 |
|
D-Max 20,000unit capsules
0906040G0DEACDR
|
D-Max | Colecalciferol | Nutrition and Blood | 3 |
|
D-Max 5,000unit capsules
0906040G0DEAAEA
|
D-Max | Colecalciferol | Nutrition and Blood | 3 |
|
D-mine Pen injection pen reusable for 3ml cartridge
21010900638
|
D-mine Pen injection pen reusable for 3ml cartridge | Other Appliances | Appliances | 3 |
|
Daddy Bear paediatric sterile leg bag 350ml adjustable inlet
22502085022
|
Daddy Bear paediatric sterile leg bag 350ml adjustable inlet | Leg Bags | Incontinence Appliances | 3 |
|
Dalacin C 75mg capsules
0501060D0BBAAAA
|
Dalacin C | Clindamycin hydrochloride | Infections | 3 |
|
Daxas 250microgram tablets
0303030B0BBABAB
|
Daxas | Roflumilast | Respiratory System | 3 |
|
Deca-Durabolin 50mg/1ml solution for injection ampoules
0604030L0BBABAB
|
Deca-Durabolin (Steroid) | Nandrolone decanoate | Endocrine System | 3 |
|
Deep Freeze spray
1003020Y0BDAAAB
|
Deep Freeze | Freeze sprays and gels | Musculoskeletal and Joint Diseases | 3 |
|
Deep Skin Cleanser
190205500BCMXA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | 3 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.